CN Stock MarketDetailed Quotes
600062 China Resources Double-Crane Pharmaceutical
- 21.65
- +0.18+0.84%
Trading Nov 5 14:32 CST
22.50BMarket Cap16.69P/E (TTM)
21.75High21.27Low177.08KlotVolume21.50Open21.47Pre Close381.25MTurnover1.72%Turnover Ratio16.87P/E (Static)1.04BShares26.1552wk High2.21P/B22.23BFloat Cap15.6852wk Low23.62Limit Up1.03BShs Float36.13Historical High19.32Limit Down2.24%Amplitude-1.75Historical Low0.36Dividend TTM21.53Avg Price89.94KlotAsk1.65%Div YieldTTM100Lot Size84.60KlotBid
China Resources Double-Crane Pharmaceutical Key Stats
EPS
According to the latest financial report of China Resources Double-Crane Pharmaceutical, the latest earnings per share (TTM) for the company is 1.36. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out China Resources Double-Crane Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 9.81.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of China Resources Double-Crane Pharmaceutical shows that the company's current ratio is 1.59, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of China Resources Double-Crane Pharmaceutical, the quick ratio is 1.26, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of China Resources Double-Crane Pharmaceutical? The latest ROE figure is 12.47%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of China Resources Double-Crane Pharmaceutical, the total asset return on investment (ROA) is 8.83%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check China Resources Double-Crane Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 58.46%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of China Resources Double-Crane Pharmaceutical, the net profit margin is 16.52%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data